Request Discount

Blood Culture Test Market (Method - Conventional/Manual Methods, and Automated Methods; Product - Consumables, Instruments, Software and Services; Technology - Culture-based Technology, Molecular Technologies, and Proteomics Technology; Application - Bacteremia, Fungemia and Mycobacterial Detection; End User - Hospital Laboratories, Reference Laboratories, Academic Research Laboratories and Other Laboratories): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : December, 2019

  • Rep Id : HC0771

  • Category : Healthcare & Medical Devices

  • Status : Published

This report provides exclusive insights into the COVID-19 impact on the Blood Culture Test Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Blood Culture Test Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Blood Culture Test Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.

A recent report published by Infinium Global Research on the blood culture test market provides an in-depth analysis of segments and sub-segments in the global as well as regional blood culture test market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional blood culture test market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global blood culture test market. According to the report, the global blood culture test market is projected to grow at a CAGR of 7.5% over the forecast period of 2019-2025.

 

Market Insight

Blood culture is the test that is used to check bacterial infection, yeast infection as well as other microorganisms in the blood. A positive blood culture indicates the presence of bacteria in the blood while negative blood culture indicates the unavailability of the bacteria. According to the WHO report, Urinary Tract Infections (UTIs) and surgical-site wound infections are mostly found in developing countries as compared to developed countries. The FDA has approved a fully automated blood culture system, which is commercially available in countries like the USA that recognize CE marks.

 

The growing population that leads to the increasing prevalence of the various infectious disease is the driving factor of the blood culture test market. Furthermore, the increasing demand for rapid diagnostic techniques and the increase in R&D initiatives by the healthcare industries are boosting the blood culture test market. Regulatory approval is required for diagnostic products such as kits, media, and instruments. This led to a delay in product launch and a rise in the cost of the diagnostic products. However, the high cost of novel techniques and stringent government regulations are the factors hampering the blood culture test market. Increasing government initiatives regarding awareness of the disease offer favorable opportunities for the blood culture test market. As the product has to face different clinical trial phases that can be a challenge for the blood culture test market.

 

Geographically, North America is the dominant region in the blood culture test market due to the presence of a large number of healthcare companies such as Thermo Fisher Scientific, Roche Diagnostics. The Asia Pacific holds the second largest market share in the blood culture test market. The increasing infectious disease, as well as growing healthcare infrastructure, are boosting the blood culture test market in the Asia Pacific. Europe is expected to grow at a healthy CAGR in the forecast period due to the growing investments in R&D by the healthcare industry.

 

Segment Covered

The report on the global blood culture test market covers segments such as method, product, technology, application, and end user. On the basis of method, the sub-markets include conventional/manual methods, and automated methods. On the basis of product, the sub-markets include consumables, and instruments. On the basis of technology, the sub-markets include culture-based technology, and molecular technologies. On the basis of application, the sub-markets include bacteremia, and fungemia. On the basis of end user, the sub-markets include hospital laboratories, reference laboratories, and other laboratories.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Becton, Dickinson and Company, Biomérieux SA, Cepheid, Nanosphere, Inc., Bruker Corporation, Beckman Coulter, Roche Diagnostics, and T2 Biosystems.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the blood culture test market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount